Should cannabis be used in the management of endometriosis?

doi:10.1080/17446651.2025.2572339

Should cannabis be used in the management of endometriosis?

2025-10-01

0

PRE

AI

DOI：10.1080/17446651.2025.2572339

Original

Original request for help

Save

Abstract

En 中文

Introduction Endometriosis is a chronic inflammatory condition that affects around 1 in 7 women of reproductive age. Current medical treatments tend to be sub-optimal to manage the range of symptoms, with low levels of patient satisfaction. Cross-sectional and retrospective data suggests that people with endometriosis are consuming cannabis to help manage their symptoms. Areas covered This review discusses the evidence for consumption of medicinal cannabis to help manage endometriosis symptoms, including potential mechanisms of action from both animal models and human studies, usage in the community, the current evidence from clinical trials and observational studies, and the safety and potential drug interactions. Expert opinion While there is a lack of high-quality clinical trial evidence, significant self-reported evidence from cross-sectional surveys and retrospective observational data suggests that those consuming medicinal cannabis report reductions in endometriosis symptoms such as pelvic pain, dysmenorrhea and gastrointestinal symptoms, and improve mental health and sleep. Given the low levels of satisfaction with current treatment options, consideration should be given to trialing medicinal cannabis as part of the interdisciplinary management of endometriosis in those who express interest and who do not demonstrate any significant contraindications.

Keywords:

Endometriosis

pelvic pain

dysmenorrhea

cannabis

cannabidiol

delta-9-tetrahydrocannabinol

Should cannabis be used in the management of endometriosis?

Abstract

Journal

Organization